Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone versus sufentanil PCA after colorectal surgery
ChiCTR-IPR-15007112Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Sep 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of hydromorphone and sufentanil in postoperative pain (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: VAS pain scores at rest and during coughing, PHS pain score and 2 more. Planned start Sep 2015; status: not yet recruiting.
02
Drugs
hydromorphonesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR-IPR-15007112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007112.